Currently the Centers for Medicare & Medicaid have announced the following open proposed rules,
CMS Acts to Strengthen Care Quality, Cut Drug Costs, and Slash Out-of-Pocket Expenses for Medicare Beneficiaries
In a move aimed at reshaping how Medicare pays for certain outpatient care services, CMS announced a proposed rule that would revise payment policies and rates for hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs) beginning in Calendar Year (CY) 2027 — signaling a renewed federal push to lower costs for Medicare beneficiaries, safeguard taxpayer investments, and strengthen access to high-quality care across the country.
CY 2027 Hospital Outpatient Prospective Payment System & Ambulatory Surgical Center Proposed Rule
CMS issued a proposed rule that would update Medicare payment policies and rates for hospital outpatient and ambulatory surgical center (ASC) services under the Hospital Outpatient Prospective Payment System (OPPS) and ASC Payment System Proposed Rule for CY 2027. CMS is publishing this proposed rule consistent with the legal requirements to update Medicare payment policies for hospital outpatient and ASCs annually.
CY 2027 Home Health Prospective Payment System Proposed Rule
CMS issued a proposed rule that announces policy changes under the Home Health (HH) Prospective Payment System (PPS), consistent with the legal requirements to update Medicare payment policies for home health agencies (HHAs) annually.
CY 2027 End-Stage Renal Disease Prospective Payment System Proposed Rule
CMS issued a proposed rule to update payment rates and policies under the Medicare End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for renal dialysis services furnished to Medicare beneficiaries on or after January 1, 2027. This rule also proposes updates to the acute kidney injury dialysis payment rate for renal dialysis services furnished by ESRD facilities for CY 2027 and proposes to update requirements for the ESRD Quality Incentive Program.
CMS Proposed Rule Locks in Lower Prices & Fosters Innovation for the Medicare Drug Price Negotiation Program
A new proposal from CMS would establish a permanent framework for the Medicare Drug Price Negotiation Program, creating a more transparent and sustainable process for lowering drug costs for millions of Medicare beneficiaries. The proposed rule would also create greater long-term certainty for drug manufacturers that participate in negotiations. It includes policies for negotiating and renegotiating high-cost, single-source drugs beginning with initial price applicability year 2029, while continuing to support innovation and strengthen the program.